Covered recipient · General Payments record
MADELINE SUSAN O DONNELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$820.37
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.99 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $81.24 | 4 |
| Exact Sciences Corporation | $46.60 | 2 |
| Astellas Pharma US Inc | $43.05 | 2 |
| PFIZER INC. | $37.71 | 2 |
| Novo Nordisk AS | $35.86 | 2 |
| Lilly USA, LLC | $20.85 | 1 |
| Janssen Pharmaceuticals, Inc | $19.49 | 1 |
| Merck Sharp & Dohme Corporation | $19.22 | 1 |
| Amgen Inc. | $17.60 | 1 |
| Acerta Pharma LLC | $15.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.10 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107750826 | CMS |
| ABBVIE INC. | $22.83 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107750828 | CMS |
| ABBVIE INC. | $18.15 | 12/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107750830 | CMS |
| ABBVIE INC. | $18.16 | 12/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107750832 | CMS |
| Amgen Inc. | $17.60 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643631 | CMS |
| Astellas Pharma US Inc | $22.32 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139516241 | CMS |
| Astellas Pharma US Inc | $20.73 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139539068 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.37 | 11/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104588250 | CMS |
| Exact Sciences Corporation | $27.98 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114559052 | CMS |
| Exact Sciences Corporation | $18.62 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114559056 | CMS |
| Janssen Pharmaceuticals, Inc | $19.49 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078150795 | CMS |
| Lilly USA, LLC | $20.85 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135770954 | CMS |
| Merck Sharp & Dohme LLC | $19.22 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141983987 | CMS |
| Novo Nordisk Inc | $19.34 | 01/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100586350 | CMS |
| Novo Nordisk Inc | $16.52 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100612815 | CMS |
| PFIZER INC. | $15.57 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131159847 | CMS |
| PFIZER INC. | $22.14 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131293803 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.